BLOOD CANCER AND PANCREATIC DISEASE DRUGS TO BE TESTED – COVID-19

Highlights –

• UK plans to introduce two new clinical trials on COVID-19 patients.
• Patients will be given blood cancer and pancreatic disease drugs.
• Drug – Ruxolitinib, used to treat various blood cancer patients.
• Drug – Camostat, used to treat inflammation of the pancreas.

In a new development by the UK, two drugs previously used in treating ....